Results per Page:
HIV reservoir decay rates defined for children receiving ART
From Dr. Daniel Reeves and colleagues, Fred Hutch Vaccine & Infectious Disease Division and UW Global Health
Cytomegalovirus has an activity shift following CAR T-cell therapy
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
New insights into T cell function in multiple myeloma patients
From the Newell Lab, Vaccine and Infectious Disease Division
AMP-ed on HIV prevention
From the McElrath Lab, Vaccine and Infectious Disease Division
Natural born killers: harnessing innate immunity to fight severe infections
From the Joshua Hill lab, Vaccine and Infectious Disease Division
One shot to save lives: Can a single HPV vaccine dose do the trick in children living with HIV?
From the Duerr lab, Vaccine and Infectious Disease Division
Breaking down barriers to clinical trial participation for people living with HIV
From the Menon group, Vaccine and Infectious Disease Division
Resulta que los antivirales contra el VHS están (y no están) a flor de piel
Del Laboratorio Zhu, División de Vacunas y Enfermedades Infecciosas
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
Inching closer to an EBV vaccine?
From the McGuire lab, Vaccine and Infectious Diseases Division
COVID-19 prior to cellular therapy is likely not a cause for alarm.
From the Hill Group, Clinical Research Division and Vaccine and Infectious Disease Division
HIV prevention: does 1+1 = 2?
From HIV Vaccine Trials Network and the HIV Prevention Trials Network, Vaccine and Infectious Disease Division
In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia
From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
When the amount of NS1 matters!
From the Blanco-Melo lab, Vaccine and Infectious Disease Division
Obstáculos relacionados con la interseccionalidad para la atención médica del VIH y las ITS en las comunidades transgénero y no binaria del estado de Washington
Del Comité Asesor de Salud Sexual Trans y No Binaria de Seattle (STARS por sus siglas en inglés) y del Grupo Duerr de Resultados, Prevención y Epidemiología del VIH (HOPE por sus siglas en inglés)
Pertussis vaccination coverage and incidence in King County, Washington
From the Halloran Group, Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Disease Division
Respiratory syncytial virus infection among people experiencing homelessness
From Dr. Denise McCulloch, Vaccine and Infectious Disease Division, Fred Hutch and Division of Allergy and Infectious Diseases, UW, and colleagues
Liver-humanized mice to study hepatis B virus infection
From the Jerome lab, Vaccine and Infectious Disease Division
Bystander-activation of CD8 T cells during Herpes Virus 2 infection
From the Lund lab, Vaccine and Infection Disease Division
Cross-neutralizing Monoclonal Antibodies Against Respiratory Viruses
From the Boonyaratanakornkit, Taylor and Pancera labs, Vaccine and Infectious Disease Division and Cancer Immunology Program, Cancer Consortium